Cargando…
A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects
Rationale: The heat shock protein (Hsp) system plays important roles in cancer stem cell (CSC) and non-CSC populations. However, limited efficacy due to drug resistance and toxicity are obstacles to clinical use of Hsp90 inhibitors, suggesting the necessity to develop novel Hsp90 inhibitors overcomi...
Autores principales: | Lee, Ho Jin, Min, Hye-Young, Yong, Young-Sik, Ann, Jihyae, Nguyen, Cong Truong, La, Minh Thanh, Hyun, Seung Yeob, Le, Huong Thuy, Kim, Hyewon, Kwon, Hyukjin, Nam, Gibeom, Park, Hyun-Ju, Lee, Jeewoo, Lee, Ho-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690924/ https://www.ncbi.nlm.nih.gov/pubmed/34987637 http://dx.doi.org/10.7150/thno.63788 |
Ejemplares similares
-
Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
por: Hyun, Seung Yeob, et al.
Publicado: (2018) -
A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer
por: Park, Jung Min, et al.
Publicado: (2020) -
The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells
por: Park, Soeun, et al.
Publicado: (2021) -
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
por: Kim, Ji Young, et al.
Publicado: (2022) -
Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly
por: Hyun, Seung Yeob, et al.
Publicado: (2022)